ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

40 Years Later: Doctor and Patient Reflect on the Cure

October 24, 2014

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

Foundation For COG Is New Name Of NCCF.

October 19, 2001

Regions Outlined In CIS Proposal

May 31, 1991

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011